Total Payments
$825.08
2024 Payments
$503.23
Companies
7
Transactions
50
Medicare Patients
6,836
Medicare Billing
$389,226
Payment Breakdown by Category
Food & Beverage$814.62 (98.7%)
Education$10.46 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $814.62 | 49 | 98.7% |
| Education | $10.46 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $334.86 | 24 | $0 (2024) |
| Amgen Inc. | $275.49 | 14 | $0 (2024) |
| Boston Scientific Corporation | $70.24 | 3 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $56.34 | 4 | $0 (2023) |
| iRhythm Technologies, Inc. | $32.04 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $28.96 | 2 | $0 (2024) |
| Novo Nordisk Inc | $27.15 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $503.23 | 34 | Novartis Pharmaceuticals Corporation ($230.29) |
| 2023 | $308.10 | 15 | Amgen Inc. ($114.01) |
| 2018 | $13.75 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($13.75) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Cardiology | ||||||
| 10/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: Cardiology | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $4.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $35.15 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/23/2024 | Amgen Inc. | Repatha (Biological) | Education | In-kind items and services | $10.46 | General |
| Category: Cardiology | ||||||
| 08/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $32.16 | General |
| Category: Cardiology | ||||||
| 08/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Obesity | ||||||
| 07/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Cardiology | ||||||
| 05/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.70 | General |
| Category: Cardiovascular | ||||||
| 05/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.26 | General |
| Category: Cardiovascular | ||||||
| 04/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,641 | 1,769 | $270,150 | $91,070 |
| 2022 | 15 | 1,966 | 2,135 | $310,069 | $103,134 |
| 2021 | 16 | 1,647 | 1,925 | $266,379 | $100,810 |
| 2020 | 18 | 1,582 | 1,890 | $261,294 | $94,212 |
Total Patients
6,836
Total Services
7,719
Medicare Billing
$389,226
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 418 | 469 | $114,874 | $41,612 | 36.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 104 | 121 | $41,987 | $15,633 | 37.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 111 | 114 | $16,366 | $5,870 | 35.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 38 | 38 | $16,226 | $5,708 | 35.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $13,566 | $5,081 | 37.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 64 | 64 | $11,790 | $3,553 | 30.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 259 | 300 | $13,602 | $2,731 | 20.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 231 | 242 | $8,740 | $2,673 | 30.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 136 | 136 | $11,152 | $2,383 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 59 | $8,506 | $1,795 | 21.1% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 16 | 19 | $6,524 | $1,446 | 22.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 63 | 63 | $2,743 | $963.59 | 35.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 63 | 63 | $1,801 | $642.51 | 35.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $1,519 | $606.35 | 39.9% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 24 | 26 | $754.00 | $374.66 | 49.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 510 | 580 | $110,200 | $44,445 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 210 | 236 | $31,624 | $12,285 | 38.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 81 | 81 | $20,007 | $8,217 | 41.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 58 | 61 | $16,226 | $7,183 | 44.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 575 | 621 | $49,059 | $5,384 | 11.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 94 | 96 | $16,896 | $4,688 | 27.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 73 | 73 | $11,169 | $4,365 | 39.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $8,150 | $3,469 | 42.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 53 | 53 | $9,328 | $2,580 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 24 | 27 | $5,130 | $2,013 | 39.2% |
About Dr. Brian Dulin, MD
Dr. Brian Dulin, MD is a Internal Medicine healthcare provider based in Greenville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1841497203.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Dulin, MD has received a total of $825.08 in payments from pharmaceutical and medical device companies, with $503.23 received in 2024. These payments were reported across 50 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($814.62).
As a Medicare-enrolled provider, Dulin has provided services to 6,836 Medicare beneficiaries, totaling 7,719 services with total Medicare billing of $389,226. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Greenville, OH
- Active Since 06/29/2007
- Last Updated 05/10/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1841497203
Products in Payments
- LEQVIO (Drug) $334.86
- Repatha (Biological) $275.49
- LifeVest (Device) $56.34
- WATCHMAN FLX (Device) $35.15
- ZIO XT Patch (Device) $32.04
- CAMZYOS (Drug) $28.96
- BodyGuardian (Device) $14.89
- Wegovy (Drug) $13.82
- Ozempic (Drug) $13.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Greenville
Stephen Dyar, Md, MD
Internal Medicine — Payments: $381,835
Internal Medicine $381,835
Dr. John Catanzaro, Md, MD
Internal Medicine — Payments: $331,996
Internal Medicine $331,996
Bhumika Patel, M.d, M.D
Internal Medicine — Payments: $208,547
Internal Medicine $208,547
Dr. Thomas Gallaher, M.d, M.D
Internal Medicine — Payments: $208,355
Internal Medicine $208,355
Bruce Gray, D.o, D.O
Internal Medicine — Payments: $166,102
Internal Medicine $166,102
Dr. Mark Purcell, Do, DO
Internal Medicine — Payments: $135,587
Internal Medicine $135,587